Cargando…

A prognostic nomogram based on competing endogenous RNA network for clear‐cell renal cell carcinoma

BACKGROUND: Clear‐cell renal cell carcinoma (ccRCC) is stubborn to traditional chemotherapy and radiation treatment, which makes its clinical management a major challenge. Recently, we have made efforts in understanding the etiology of ccRCC. Increasing evidence revealed that the competing endogenou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Yun, Wu, Shangrong, Xu, Zihan, Hou, Dingkun, Li, Nan, Zhang, Zheyu, Wang, Lili, Wang, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366097/ https://www.ncbi.nlm.nih.gov/pubmed/34196116 http://dx.doi.org/10.1002/cam4.4109

Ejemplares similares

Development and validation of a PBRM1‐associated immune prognostic model for clear cell renal cell carcinoma
por: Chen, Jiayi, et al.
Publicado: (2021)

Integrated analysis of long noncoding RNA associated‐competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma
por: Yin, Hang, et al.
Publicado: (2018)

Systematic Evaluation of the Prognostic Impact and Intratumour Heterogeneity of Clear Cell Renal Cell Carcinoma Biomarkers
por: Gulati, Sakshi, et al.
Publicado: (2014)

Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm
por: Luo, Jun, et al.
Publicado: (2020)

Key sunitinib‐related biomarkers for renal cell carcinoma
por: Peng, Yun, et al.
Publicado: (2021)

Influence of gene expression on survival of clear cell renal cell carcinoma
por: Berglund, Anders, et al.
Publicado: (2020)

Identification of an endogenous retroviral signature to predict anti-PD1 response in advanced clear cell renal cell carcinoma: an integrated analysis of three clinical trials
por: Zhou, Jian-Guo, et al.
Publicado: (2022)

Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma
por: Lin, Shitong, et al.
Publicado: (2020)

Identification of a lncRNA-associated competing endogenous RNA-regulated network in clear cell renal cell carcinoma
por: Liu, Beibei, et al.
Publicado: (2019)

Development and validation of prognostic nomogram for elderly patients with clear cell renal cell carcinoma based on the SEER database
por: Lin, Mingxin, et al.
Publicado: (2023)

Identification of a competing endogenous RNA network related to immune signature in clear cell renal cell carcinoma
por: Zhang, Yuke, et al.
Publicado: (2021)

Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
por: Xia, Zhi-Nan, et al.
Publicado: (2022)

Construction and validation of a prognostic nomogram for anal squamous cell carcinoma
por: Yang, Ningning, et al.
Publicado: (2021)

Development of an Autophagy-Related Gene Prognostic Model and Nomogram for Estimating Renal Clear Cell Carcinoma Survival
por: Wang, Ying, et al.
Publicado: (2021)

A comprehensive characterization of the transcriptome in enzalutamide resistance prostate cancer
por: Wang, Lili, et al.
Publicado: (2021)

CCL2 as a potential therapeutic target for clear cell renal cell carcinoma
por: Arakaki, Ryuichiro, et al.
Publicado: (2016)

Etiologic heterogeneity of clear‐cell and papillary renal cell carcinoma in the Netherlands Cohort Study
por: van de Pol, Jeroen A. A., et al.
Publicado: (2020)

Characterizing Tumor Thrombus Arising from Non–Clear Cell Renal Cell Carcinoma
por: Rabinowitz, Matthew J., et al.
Publicado: (2022)

A novel prognostic nomogram based on 5 long non-coding RNAs in clear cell renal cell carcinoma
por: Wang, Sheng, et al.
Publicado: (2019)

Identification of small molecule drugs and development of a novel autophagy‐related prognostic signature for kidney renal clear cell carcinoma
por: Xing, Qianwei, et al.
Publicado: (2020)

A nomogram based on 9-lncRNAs signature for improving prognostic prediction of clear cell renal cell carcinoma
por: Jiang, Wen, et al.
Publicado: (2019)

Low level of Cyclin‐D1 correlates with worse prognosis of clear cell renal cell carcinoma patients
por: Wang, Qing‐shui, et al.
Publicado: (2019)

First-Line Treatments for Metastatic Clear Cell Renal Cell Carcinoma: An Ever-Enlarging Landscape
por: Gulati, Shuchi, et al.
Publicado: (2022)

Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas
por: Yao, Masahiro, et al.
Publicado: (2014)

The first competing risk survival nomogram in patients with papillary renal cell carcinoma
por: Su, Xing, et al.
Publicado: (2021)

Detection of dysregulated competing endogenous RNA modules associated with clear cell kidney carcinoma
por: Wang, Hong, et al.
Publicado: (2018)

Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs
por: Wang, Hongyan, et al.
Publicado: (2020)

Circular RNA-Associated Competing Endogenous RNA Network and Prognostic Nomogram for Patients With Colorectal Cancer
por: Song, Wei, et al.
Publicado: (2019)

Development and validation of nomogram to predict risk of survival in patients with laryngeal squamous cell carcinoma
por: Cui, Jie, et al.
Publicado: (2020)

Author Correction: Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma
por: Xia, Zhi-Nan, et al.
Publicado: (2023)

HOTAIRM1 competed endogenously with miR‐148a to regulate DLGAP1 in head and neck tumor cells
por: Zheng, Mei, et al.
Publicado: (2018)

Abnormal oxidative metabolism in a quiet genomic background underlies clear cell papillary renal cell carcinoma
por: Xu, Jianing, et al.
Publicado: (2019)

Preclinical evaluation of an unconventional ruthenium‐gold‐based chemotherapeutic: RANCE‐1, in clear cell renal cell carcinoma
por: Elie, Benelita T., et al.
Publicado: (2019)

Comparative Effectiveness of Front-Line Ipilimumab and Nivolumab or Axitinib and Pembrolizumab in Metastatic Clear Cell Renal Cell Carcinoma
por: Zarrabi, Kevin K, et al.
Publicado: (2022)

Comprehensive subgroup analyses of survival outcomes between clear cell renal cell adenocarcinoma and papillary renal cell adenocarcinoma
por: Huang, Jingyi, et al.
Publicado: (2020)

Prognostic Nomogram Based on Circular RNA-Associated Competing Endogenous RNA Network for Patients with Lung Adenocarcinoma
por: Li, Yang, et al.
Publicado: (2021)

Identification of a competing endogenous RNA axis “SVIL‐AS1/miR‐103a/ICE1” associated with chemoresistance in lung adenocarcinoma by comprehensive bioinformatics analysis
por: Guo, Lili, et al.
Publicado: (2021)

Patterns of distant metastases in patients with clear cell renal cell carcinoma––A population‐based analysis
por: Xue, Jianxin, et al.
Publicado: (2020)

A MUCINs expression signature impacts overall survival in patients with clear cell renal cell carcinoma
por: Meng, Hui, et al.
Publicado: (2021)

Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer
por: Liao, Lili, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k69c9nk4rogjut0t4vbtq23b63